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Available online 15 January 2011Pristanic acid (Prist) is accumulated in various peroxisomal disorders characterized by
severe neurological dysfunction whose pathogenesis is poorly understood. Since oxidative
damage has been demonstrated in brain of patients affected by neurodegenerative
disorders, in the present work we investigated the in vitro effects of Prist on important
parameters of oxidative stress in cerebral cortex from young rats. Prist significantly
increased malondialdehyde levels, reflecting an increase of lipid peroxidation. This effect
was totally prevented by the free radical scavenger melatonin, suggesting the involvement
of reactive species. Prist also provoked protein oxidative damage, as determined by
increased carbonyl formation and sulfhydryl oxidation. Otherwise, it did not alter nitric
oxide production, indicating that nitrogen reactive species were not implicated in the lipid
and oxidative damage provoked by Prist. Furthermore, the concentration of glutathione
(GSH), the major brain non-enzymatic antioxidant defense, was significantly decreased by
Prist and this decrease was fully prevented by melatonin and attenuated by α-tocopherol. It
is therefore presumed that Prist elicits oxidative stress in the brain probably via reactive
oxygen species formation and that this pathomechanism may possibly be involved in the
brain damage found in patients affected by peroxisomal disorders where Prist accumulates.
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Fig. 1 – In vitro effect of pristanic acid (Prist) on thiobarbituric
acid-reactive substances (TBA-RS) values in rat cerebral
cortex (A).Cortical supernatantswere incubatedduring1h in the
presence of Prist at concentrations ranging from1 to 200μM (A).
In some experiments 200 μM Prist was co-incubated during 1
h with the antioxidants 1.0 mMmelatonin (MEL), 10 μMTrolox
(TRO, solubleα-tocoferol), combinationof 20mU/mLsuperoxide
dismutase (SOD) plus 20 mU/mL catalase (CAT), 1.0 mM
reduced glutathione (GSH), 1 mMN-acetylcysteine (NAC) or
750 μMNω-nitro-L-arginine methyl ester (L-NAME) (B). Values
are means±standard deviation for six independent (animals)
experiments performed in triplicate and are expressed as
percentage of controls (Controls: TBA-RS levels (A): 2.70±0.64
nmol/mg protein; (B): 3.28±0.73 nmol/mg protein. **P<0.01,
***P<0.001, compared to control; ###P<0.001, compared to
200 μM Prist (Duncanmultiple range test).
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Pristanic acid (Prist) (2,6,10,14-tetramethylpentadecanoic
acid), a branched-chain fatty acid derived from peroxisomal
α-oxidation of phytanic acid, accumulates in various inherited
peroxisomal disorders (Wanders et al., 2001). These disorders
can be due to a single-protein defect or by peroxisome
biogenesis disorders. The first group comprehends defects in
which a single metabolic function is deficient, whereas the
second is characterized by a deficiency of peroxisome
biogenesis leading to an impairment of multiple peroxisome
functions (Gould et al., 2001; Wanders et al., 2001; Brosius and
Gartner, 2002). The frequency of these disorders is estimated
in 1:20,000–1:100,000 births (Gould et al., 2001; Wanders et al.,
2001; Brosius and Gartner, 2002). The highest concentrations
of Prist occurs in D-bifunctional protein and α-methylacyl-CoA
racemase deficiencies (single-protein defects), as well as in
Zellweger syndrome (peroxisome biogenesis disorders) (Gould
et al., 2001; Wanders et al., 2001; Brosius and Gartner, 2002;
Johnson et al., 2003; Ronicke et al., 2009) achieving 100–300 μM in
plasmaof the affected patients (Zomer et al., 2000; Ferdinandusse
et al., 2002).
The clinical presentation of these disorders is predomi-
nantly characterized by neurological symptoms, such as
hypotonia, global developmental delay and seizures, although
abnormal facial appearance, feeding difficulty and liver
disease also occur (Gould et al., 2001; Wanders et al., 2001;
Brosius and Gartner, 2002). The most common findings in
magnetic resonance imaging (MRI) involve progressive white
matter abnormalities and cortical atrophy (Gould et al., 2001;
Wanders et al., 2001), whose pathophysiology is poorly known.
However, it was recently shown that Prist increases the
intracellular Ca2+ level and reduces the mitochondrial mem-
brane potential, besides inducing reactive oxygen species
production and cell death in hippocampal neurons, astrocytes
and oligodendrocytes (Ronicke et al., 2009). Furthermore,
Zomer and colleagues (2000) demonstrated that Prist is a
naturally occurring ligand for the peroxisome proliferator-
activated receptor α (PPARα), which plays an important role in
the regulation of genes involved in lipid homeostasis.
Therefore, Prist might possibly contribute to the pathology of
peroxisomal disorders by activating PPARα when found at
pathological concentrations.
In the present study we investigated the role of Prist on
important biochemical parameters of oxidative stress, name-
ly, thiobarbituric acid-reactive substances (TBA-RS) (lipid
peroxidation), sulfhydryl content and carbonyl formation
(protein oxidative damage), reduced glutathione (GSH) levels
and nitric oxide production in cerebral cortex of young rats in
the hope to clarify the underlying mechanisms inducing
neurotoxic effects of this fatty acid.2. Results
2.1. Prist induces lipid oxidation
Theeffect of Prist on lipidoxidationwas investigatedbyassessing
TBA-RS levels in rat brain. Fig. 1A shows that TBA-RS valuesweresignificantly increased (up to 45%) in cortical supernatants
exposed for 1 h to Prist [F(4,25)=12.494; P<0.001] in a dose-
dependent manner [β=0.768; P<0.001]. Considering that TBA-RS
reflects the amount of malondialdehyde formed in the medium,
which is a product of lipid oxidation. These data suggest that Prist
induces lipid oxidative damage.
We then evaluated the role of antioxidants on Prist-
induced increase of TBA-RS levels. Cortical supernatants
were co-incubated with the antioxidants MEL (1000 μM), TRO
(10 μM), combination of SOD plus CAT (20 mU/mL each), GSH
(1000 μM), NAC (1000 μM) or L-NAME (750 μM) in the presence
of 200 μM Prist. Fig. 1B shows that MEL totally prevent Prist-
induced in vitro lipoperoxidation [F(7,24)=8.805; P<0.001]. These
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induced increase of lipid peroxidation.
2.2. Prist induces protein oxidative damage
Thenext setof experimentswas carriedout to evaluate the in vitro
effect of Prist on carbonyl and sulfhydryl content in cortical
supernatants from young rats, which are parameters that
evaluate protein oxidative damage. Prist significantly increased
carbonyl formation at 100 μM and higher concentrations (up to
87%) [F(4,19)=10.409; P<0.01] (Fig. 2A). This branched-chain fatty
acid alsoprovokedanenhancementof sulfhydryl oxidation (up to
33%) [F(4,25)=18.877; P<0.001] in a dose-dependent manner [β=
−0.860; P<0.001] (Fig. 2B). Considering that carbonyl originates
from the attack of free radicals to proteins and the sulfhydryl
groups are oxidized by these reactive radicals, it is therefore
presumed that Prist induces protein oxidative damage.
2.3. Prist diminishes non-enzymatic antioxidant defenses
The non-enzymatic antioxidant defenses were also investigated
by assessing the concentrations of GSH, the naturally occurring
antioxidant found in the brain, in the presence of Prist in corticalFig. 2 – In vitro effect of pristanic acid (Prist) on carbonyl and
sulfhydryl content in rat cerebral cortex. Cortical supernatants
were incubated during 1 h in the presence of Prist at
concentrations ranging from 1 to 200 μM. Values are means ±
standard deviation for five to six independent (animals)
experiments performed in triplicate and are expressed as
percentage of controls (Controls: carbonyl content (A): 0.42±0.07
nmol/mg protein; sulfhydryl content (B): 69.9±8.3 nmol/mg
protein). *P<0.05, **P<0.01, ***P<0.001, compared to controls
(Duncan multiple range test).supernatants. It can be seen in Fig. 3A that Prist significantly
diminished GSH levels (up to 28%) in a dose-dependent manner
[F(4,19)=19.489; P<0.001] [β=−0.845; P<0.001]. It is therefore con-
cluded that Prist reduces the major brain antioxidant defense.
It was also tested whether the antioxidants MEL (1000 μM),
TRO (10 μM), combination of SOD plus CAT (20mU/mL each) or
L-NAME (750 μM) could prevent Prist-induced decrease of GSH
levels in cortical supernatants. Fig. 3B shows that MEL [F(5,24)=
30.334; P<0.001] fully prevented and TRO [F(5,24) =30.334;
P<0.001] attenuated Prist-induced decrease of GSH levels.
The data indicate that Prist-elicited diminution of GSH
concentrations occurred via reactive oxygen species.Fig. 3 – In vitro effect of pristanic acid (Prist) on reduced
glutathione (GSH) levels (A) in rat cerebral cortex. Cortical
supernatants were incubated during 1 h in the presence of
Prist at concentrations ranging from 1 to 200 μM (A). In some
experiments 200 μM Prist was co-incubated during 1 h with
the antioxidants 1.0 mM melatonin (MEL), 10 μM Trolox
(TRO, soluble α-tocoferol), combination of 20 mU/mL
superoxide dismutase (SOD) plus 20 mU/mL catalase (CAT),
1.0 mM reduced glutathione (GSH), 1 mM N-acetylcysteine
(NAC) or 750 μM Nω-nitro-L-arginine methyl ester (L-NAME)
(B). Values are means±standard deviation for five to six
independent (animals) experiments performed in triplicate
and are expressed as percentage of controls (Controls: GSH
levels (A): 8.26±0.67 nmol/mg protein; (B): 5.05±0.47 nmol/mg
protein). *P<0.05, ***P<0.001, compared to controls; #P<0.05,
###P<0.001, compared to 200 μM Prist (Duncanmultiple range
test).
Table 1 – Effect of pristanic acid (Prist) on nitric oxide
production in rat cerebral cortex supernatants.
Nitric oxide production
Control 100 μM 200 μM
Prist 100±9.5 100±5.4 99.1±10
Values aremeans±standard deviation of six independent experiments
performed in triplicate and are expressed as percentage of controls
(Control: [nmol/mg protein]: 2.8±0.3). No significant differences were
detected (one-way ANOVA).
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In order to evaluate whether Prist could directly affect thiol
groups in a cell free medium, we exposed a commercial GSH
solution (150 μM) to 200 μM Prist for 1 h in the absence of brain
supernatants. Fig. 4 shows that Prist per se did notmodify GSH
levels, whereas N-ethylmaleimide (NEM, 150 μM) (positive
control) markedly oxidized GSH. The data clearly indicate that
Prist does not behave as a direct oxidant.
2.5. Prist does not induce nitric oxide production
Finally, we assessed whether nitrogen reactive species were
involved in Prist pro-oxidant effects by investigating the effect
of Prist on nitrate and nitrite production. It can be seen in
Table 1 that Prist did not induce nitrogen reactive species
generation in cerebral cortex from young rats. Taken together
these observations suggest that the pro-oxidant effects of Prist
were mainly due to reactive oxygen species.3. Discussion
Although patients affected by peroxisomal disorders present
severe neurological dysfunction and cerebral cortex abnormali-
ties, the pathogenesis of the brain damage in these diseases is
poorly known. However, it is presumed that Prist, that is
accumulated at high concentrations in these pathologies, may
be involved in their neuropathology (Gould et al., 2001; Wanders
et al., 2001; Brosius and Gartner, 2002). In this particular, it was
recently demonstrated that Prist is cytotoxic to neurons, astro-
cytes and oligodendrocytes prepared from rat hippocampus
(Wanders et al., 2001; Ronicke et al., 2009). Although the
mechanisms of this toxicity were not well established, it was
shown that Prist induces reactive species formation and impairs
intracellular calcium homeostasis (Ronicke et al., 2009). In the
present study we investigated the in vitro effects of Prist onFig. 4 – Effect of pristanic acid (Prist) on the concentrations of
reduced glutathione (GSH) in the absence of brain tissue. A
commercial GSH solution (150 μM) was incubated during 1
h in the presence of 200μMPrist or NEM (150μM). Values are
means±standard deviation for three independent experiments
performed in triplicate and are expressed as percentage of
controls (Control: 2341±31.5 fluorescence units). GSH content
was measured in the absence of brain tissue. NEM=N-
ethylmaleimide (positive control). ***P<0.001 compared to
controls (Duncan multiple range test).important parameters of oxidative stress, by assessing lipid and
proteinoxidativedamage,aswell as theantioxidantdefensesand
nitric oxide content in cerebral cortex of young rats in order to
clarify the pathophysiology of disorders in which Prist
accumulates.
We first observed that Prist significantly increased TBA-RS
levels, reflecting an induction of malondialdehyde generation,
an end product ofmembrane fatty acid peroxidation (Halliwell
and Gutteridge, 2007). Therefore, it is presumed that Prist
caused lipid peroxidation in vitro. As the Prist-induced lipid
oxidative damage in cerebral cortex was totally prevented by
the free radical scavenger MEL that mainly sequesters peroxyl
and hydroxyl radicals, it is conceivable that this deleterious
effect can be attributed to these oxygen reactive species.
Prist also provoked protein oxidation, as detected by a
marked increase of carbonyl formation and sulfhydryl oxida-
tion. In this context, it should be noted that carbonyl groups
(aldehydes and ketones) are mainly formed by oxidation of
protein side chains (especially Pro, Arg, Lys, and Thr), as well
as by oxidative cleavage of proteins, or by the reaction of
reducing sugars with lysine protein residues (Dalle-Donne
et al., 2003). We cannot exclude the possibility that aldehydes
resulting from lipid peroxidation may also induce carbonyl
generation (Dalle-Donne et al., 2003). Otherwise, oxidation of
protein sulfhydryl groups, especially from cysteine residues,
gives rise to disulfide bonds, altering the redox state of
proteins and potentially leading to their inactivation (Kuhn
et al., 1999). Although the exact mechanisms by which Prist
caused protein oxidationwere not investigated, it is presumed
that oxidative damage to proteins occurred through the attack
of reactive species induced by this branched-chain fatty acid.
Besides causing lipid and protein oxidative damage, Prist
significantly reduced the total content of GSH, which
corresponds to the major endogenous antioxidant in the
brain (Halliwell and Gutteridge, 2007). The reduction of GSH
levels caused by Prist was fully prevented by MEL and
attenuated by TRO, suggesting that this effect was probably
mediated by the hydroxyl and peroxyl radicals, which are
trapped by these antioxidants. Furthermore, Prist did not
change the sulfhydryl content of a commercial solution of
GSH in a cell free medium, indicating that it does not directly
oxidize thiol groups. Considering that GSH is an important
measurement of the antioxidant defenses of a tissue
(Halliwell and Gutteridge, 2007), it can be therefore assumed
that the rat cortical non-enzymatic antioxidant defenses
were compromised by Prist.
L-NAME, a selective inhibitor of nitric oxide synthase
activity, did not alter the increase of TBA-RS values and the
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fact that this fatty acid did not induce nitrogen reactive
species formation, as determined by nitrates and nitrites
generation, strongly indicate that Prist pro-oxidant effects
(induction of lipid and protein oxidative damage and reduc-
tion of GSH levels) in cerebral cortex were probably mediated
by the generation of reactive oxygen species, especially
peroxyl and hydroxyl radicals. Regarding the peroxyl radical,
which is an end product of lipid oxidation, it is conceivable
that it was produced by the oxidative attack to lipid
membranes (Delanty andDichter, 1998; Halliwell andWhiteman,
2004; Halliwell and Gutteridge, 2007). Furthermore, the hydroxyl
radical ismainly produced by the Fenton reaction fromhydrogen
peroxide, which is formed from superoxide (Adam-Vizi, 2005).
Our present data strongly indicate that Prist induces
oxidative stress in rat brain, a deleterious cell condition that
results from an imbalance between the total antioxidant
defenses and the pro-oxidant effects in a tissue (Halliwell and
Gutteridge, 2007). At this point, it should be emphasized that
the brain has low cerebral antioxidant defenses and a high
lipid and iron content compared with other tissues (Halliwell,
1992; Halliwell and Gutteridge, 2007), a fact that makes this
tissue more vulnerable to increased reactive species.
We used cortical supernatants in our present study because
these preparations are frequently used as model systems to
evaluate important pro-oxidant and antioxidant parameters of
oxidative stress (Cadenas et al., 1981; Gonzalez Flecha et al., 1991;
Lores Arnaiz and Llesuy, 1993; Llesuy et al., 1994; Evelson et al.,
2001; Halliwell and Gutteridge, 2007). In fact, tissue supernatants
contain the whole cell machinery including preserved organelles
suchasmitochondria (themajor sourceof free radical generation)
and enzymes that are necessary for free radical production and
scavenge (Stocks et al., 1974; Cadenas et al., 1981; Llesuy et al.,
1994; Evelson et al., 2001; Dresch et al., 2009).
Although other studieswith intact cellmodels are necessary
to determine the involvement of Prist on thepathophysiologyof
diseases inwhich this fatty acid accumulates, it should benoted
that the Prist-induced significant effects on the parameters of
oxidative stress in brain cortex was achieved with concentra-
tions of 100 μM, which are similar or even lower to those found
in plasma of patients affected by various peroxisomal disorders
(Zomer et al., 2000; Ferdinandusse et al., 2002). We have also to
take into account that a considerable fraction of the supple-
mented exogenous Prist was possibly bound to proteins present
in the incubationmedium, leaving a smaller portion of this acid
compound free to react and exert its effects.
On the other hand, we have recently described that phytanic
acid (Phyt), which also accumulates in some peroxisomal
disorders, provokes oxidative damage to lipids and proteins and
reduces thenon-enzymatic antioxidantdefenses, besides impair-
ing bioenergetics in rat brain (Busanello et al., 2010; Leipnitz et al.,
2010). However, the oxidative effects exerted by Phyt were
moderate and occurred with higher doses supplemented to the
incubationmedium as compared to those caused by Prist. This is
in line with previous findings obtained in cultured neural cells
demonstrating that induction of reactive oxygen species gener-
ation by Prist is greater than that provoked by Phyt (Ronicke et al.,
2009).
Inconclusion, toourknowledge, this is the first report showing
that Prist that accumulates in some peroxisomal disordersprovokes lipid and protein oxidative damage and diminishes
the antioxidant defenses in the cerebral cortex. However,
additional studies performed in intact neural cells and in animal
models of peroxisomal disorders are required to confirm the role
of oxidative stress in the pathophysiology of these diseases. In
case the in vitro effects detected in the present study are
confirmed in vivo and also in tissues from affected patients, it is
tempting to speculate that the administration of antioxidants
should be considered as an adjuvant therapy for these patients.4. Experimental procedures
4.1. Animals and reagents
Wistar male rats of 30 days of life obtained from the Central
Animal House of the Department of Biochemistry, ICBS,
Universidade Federal do Rio Grande do Sul, Porto Alegre, RS,
Brazil, were used. The animals were maintained on a 12:12
h light/dark cycle (lights on 07.00–19.00 h) in air conditioned
constant temperature (22±1 °C) colony room, with free access
to water and 20% (w/w) protein commercial chow (SUPRA,
Porto Alegre, RS, Brazil). The experimental protocol was
approved by the Ethics Committee for animal research of the
Federal University of Rio Grande do Sul, Porto Alegre, Brazil
and followed the Principles of Laboratory Animal Care (NIH
publication 85-23, revised 1996). All efforts were made to
minimize the number of animals used and their suffering.
All chemicals were purchased from Sigma (St. Louis, MO,
USA). Prist solutionwas prepared on the day of the experiments
in the incubation medium used for each technique and pHwas
adjusted to 7.4. TBA-RS, carbonyl formation, sulfhydryl content
andnitric oxide productionweremeasuredwith a double-beam
Hitachi U-2001 spectrophotometer, whereas GSH levels were
measured in a Hitachi F-2000 fluorescence spectrophotometer.
4.2. Cerebral cortex supernatant preparation
and incubation
Rats sacrificed by decapitation without anaesthesia had their
brain rapidly excised on a Petri dish placed on ice. The
olfactory bulbs, pons, medulla, cerebellum, hippocampus and
striatum were discarded, and the cerebral cortex was dissect-
ed, weighed and homogenized in 10 volumes (w/v) of 20 mM
sodium phosphate buffer, pH 7.4, containing 140 mM KCl.
Homogenates were centrifuged at 750g for 10 min at 4 °C to
discard nuclei and cell debris (Evelson et al., 2001). The pellet
was discarded and the supernatant, a suspension of mixed
and preserved organelles, including mitochondria, was pre-
incubated at 37 °C for 1 h with Prist at concentrations of 1, 10,
100 or 200 μM. Controls did not contain this fatty acid in the
incubation medium. Immediately after incubation, aliquots
were taken to measure TBA-RS, carbonyl formation, sulfhydryl
content and GSH levels. In some experiments, antioxidants were
co-incubated with supernatants at the following final concentra-
tions: 10 μMTrolox (TRO, soluble α-tocoferol), 1000 μMGSH, 1000
μMN-acetylcysteine (NAC), combinationof 20mU/mLsuperoxide
dismutase (SOD) plus 20mU/mL catalase (CAT), 750 μMNω-nitro-
L-arginine methyl ester (L-NAME) and 1000 μMmelatonin (MEL).
The chosen concentrations of the antioxidants were those
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Gutteridge, 2007).
4.3. Thiobarbituric acid-reactive substances (TBA-RS)
TBA-RS was determined according to the method of Esterbauer
and Cheeseman (1990). Briefly, 300 µL of cold 10% trichloroacetic
acid were added to 150 µL of pre-incubated cerebral cortex
supernatants and centrifuged at 3000g for 10min. Threehundred
microliters of thepre-incubated supernatantswere transferred to
a pyrex tube and incubated with 300 μL of 0.67% TBA in 7.1%
sodium sulphate on a boiling water bath for 25 min. The tubes
containing themixturewereallowedtocoolon running tapwater
for 5min.The resultingpink-stainedTBA-RSwasdetermined ina
spectrophotometer at 532nm.A calibration curvewasperformed
using 1,1,3,3-tetramethoxypropane, and each curve point was
subjected to the same treatment as supernatants. TBA-RS values
were calculated as nmol/mg protein and represented as percent-
age of control.
4.4. Protein carbonyl content
Protein carbonyl formation, a marker of protein oxidative
damage, was measured spectrophotometrically according to
Reznick and Packer (1994). Two hundred microliters of the
aliquots from the pre-treated supernatants were treated with
400 µL of 10 mM 2,4-dinitrophenylhidrazine (DNPH) dissolved in
2.5 N HCl or with 2.5 N HCl (blank) and left in the dark for 1 h.
Samples were then precipitated with 600 μL 20% trichloroacetic
acid and centrifuged for 5 min at 9000g. The pellet was then
washed with 1 mL ethanol:ethyl acetate (1:1, V/V) and dissolved
in 550 μL 6 M guanidine prepared in 2.5 N HCl at 37 ºC for 5 min.
The difference between the DNPH-treated and HCl-treated
samples (blank) was used to calculate the carbonyl content
determined at 365 nm. The results were calculated as nmol of
carbonyl groups/mg of protein and represented as percentage of
control, using the extinction coefficient of 22000×106 nmol/mL
for aliphatic hydrazones.
4.5. Sulfhydryl content
This assay is based on the reduction of 5,5′-dithio-bis(2-
nitrobenzoic acid) (DTNB) by thiols, generating a yellow
derivative (TNB) whose absorption is measured spectropho-
tometrically at 412 nm (Aksenov and Markesbery, 2001).
Briefly, 160 µL of pre-treated supernatant were incubated at
37 °C for 1 h with Prist. Then 30 μL of 10mMDTNB, prepared in
0.2 M potassium phosphate solution, pH 8.0, was added. This
was followed by 30 min incubation at room temperature in a
dark room. Absorption was measured at 412 nm. The
sulfhydryl content is inversely correlated to oxidative damage
to proteins. Results were reported as nmol/mg protein and
represented as percentage of control.
4.6. Reduced glutathione (GSH) content
GSH concentrations were measured according to Browne and
Armstrong (1998). Aliquots from the pre-treated supernatants
were diluted in 20 volumes of (1:20, v/v) 100 mM sodium
phosphate buffer, pH 8.0, containing 5 mM EDTA. Onehundred microliters of this preparation were incubated with
an equal volume of o-phthaldialdehyde (1 mg/mL methanol)
at room temperature during 15 min. Fluorescence was
measured using excitation and emission wavelengths of 350
and 420 nm, respectively. Calibration curve was prepared with
standard GSH (0.001–1 mM) and the concentrations were
calculated as nmol/mg protein and represented as percentage
of control.
4.7. Nitric oxide production
Nitric oxide production was determined by measuring its
derivatives nitrate (NO3−) and nitrite (NO2−) according to Miranda
and colleagues (2001). Vanadium chloride (200 μL) was added to
the tube containing 200 μL of Prist pre-treated cerebral cortex
supernatants for complete reduction of nitrate to nitrite. Then,
200 μL of Griess reagent (a mixture of N-1-naphtylethylenedia-
mine dihydrochloride and sulfanilamide) were added and the
tube was incubated for 30 min at 37 °C in a water bath in a dark
room. The resulting pink-stained pigment was determined in a
spectrophotometerat540nm.Acalibrationcurvewasperformed
using sodium nitrate (2.5–100 μM), and each curve point was
subjected to the same treatment as supernatants. Nitric oxide
production values were calculated as nmol/mg protein and
represented as percentage of control.
4.8. Protein determination
Protein contentwasdetermined in cerebral cortex supernatants
by the method of Lowry and colleagues (1951), using bovine
serum albumin as a standard.
4.9. Statistical analysis
Results are presented as mean±standard deviation. Assays
were performed in duplicate or triplicate and the mean or
median was used for statistical calculations. Data was
analyzed using one-way analysis of variance (ANOVA) fol-
lowed by the post-hoc Duncanmultiple range test when F was
significant. Linear regression analysis was also used to test
dose-dependent effects. Only significant F values are shown in
the text. Differences between groups were rated significant at
P<0.05. All analyses were carried out in an IBM-compatible PC
computer using the Statistical Package for the Social Sciences
(SPSS) software.Acknowledgments
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